Amgen : AMGN

All Amgen Articles

708 Articles

Jon C. Ogg | Jan 23, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Amgen, Caterpillar, Dollar General, Duke Energy, General Electric,…

Jon C. Ogg | Jan 17, 2018 at 4:15 PM EST

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Apple indicated that it will pay $38 billion in repatriation taxes under the new tax law. Apple says that it…

Chris Lange | Jan 11, 2018 at 9:50 AM EST

Short Sellers Grow More Selective on Major Biotechs

The December 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Jan 5, 2018 at 11:15 AM EST

Meet Merrill Lynch’s Top Biotech Picks for 2018

Merrill Lynch believes that this could be the year biotechs break out. The firm has a few picks, bad and…

Lee Jackson | Dec 31, 2017 at 10:15 AM EST

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be…

Chris Lange | Dec 28, 2017 at 9:05 AM EST

Major Biotechs See Surge in Short Interest

The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Dec 12, 2017 at 10:10 AM EST

Major Biotechs See Rising Tide in Short Interest

The November 30 short interest data have been compared with the previous report, and short interest in most of the…

Lee Jackson | Dec 11, 2017 at 9:50 AM EST

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Chris Lange | Nov 10, 2017 at 10:40 AM EST

Short Sellers Grow More Selective on Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech…

Lee Jackson | Nov 10, 2017 at 10:15 AM EST

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar…

Jon C. Ogg | Nov 1, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Abercrombie, Amgen, Electronic Arts, GM, Goldcorp, Shopify, 3D Systems, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Abercrombie & Fitch, Amgen, Electronic Arts, General Motors,…

Chris Lange | Oct 25, 2017 at 10:40 AM EDT

Short Sellers Chase Biotechs Higher

The October 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Chris Lange | Oct 11, 2017 at 11:35 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

1 … 17 18 19 20 21 … 48

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Short Sellers Grow More Selective on Major Biotechs

Meet Merrill Lynch’s Top Biotech Picks for 2018

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Major Biotechs See Surge in Short Interest

Major Biotechs See Rising Tide in Short Interest

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Grow More Selective on Major Biotechs

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Abercrombie, Amgen, Electronic Arts, GM, Goldcorp, Shopify, 3D Systems, Under Armour and More

Short Sellers Chase Biotechs Higher

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Short Sellers Grow More Selective on Major Biotechs

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Short Sellers Grow More Selective on Major Biotechs

Meet Merrill Lynch’s Top Biotech Picks for 2018

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Major Biotechs See Surge in Short Interest

Major Biotechs See Rising Tide in Short Interest

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Grow More Selective on Major Biotechs

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Abercrombie, Amgen, Electronic Arts, GM, Goldcorp, Shopify, 3D Systems, Under Armour and More

Short Sellers Chase Biotechs Higher

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Short Sellers Grow More Selective on Major Biotechs

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account